AU2002362461A1 - Targeted therapeutic lipid constructs having cell surface targets - Google Patents

Targeted therapeutic lipid constructs having cell surface targets

Info

Publication number
AU2002362461A1
AU2002362461A1 AU2002362461A AU2002362461A AU2002362461A1 AU 2002362461 A1 AU2002362461 A1 AU 2002362461A1 AU 2002362461 A AU2002362461 A AU 2002362461A AU 2002362461 A AU2002362461 A AU 2002362461A AU 2002362461 A1 AU2002362461 A1 AU 2002362461A1
Authority
AU
Australia
Prior art keywords
cell surface
targeted therapeutic
surface targets
lipid constructs
therapeutic lipid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002362461A
Inventor
John S. Pease
Zhi Min Shen
Charles Aaron Wartchow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Targesome Inc
Original Assignee
Targesome Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/976,254 external-priority patent/US20020071843A1/en
Application filed by Targesome Inc filed Critical Targesome Inc
Publication of AU2002362461A1 publication Critical patent/AU2002362461A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
    • A61K51/1234—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
    • A61K51/1234—Liposomes
    • A61K51/1237—Polymersomes, i.e. liposomes with polymerisable or polymerized bilayer-forming substances
AU2002362461A 2001-10-01 2002-10-01 Targeted therapeutic lipid constructs having cell surface targets Abandoned AU2002362461A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US23631001P 2001-10-01 2001-10-01
US60/236,310 2001-10-01
US09/976,254 2001-10-11
US09/976,254 US20020071843A1 (en) 2000-10-11 2001-10-11 Targeted therapeutic agents
PCT/US2002/031090 WO2003028643A2 (en) 2001-10-01 2002-10-01 Targeted therapeutic lipid constructs having cell surface targets

Publications (1)

Publication Number Publication Date
AU2002362461A1 true AU2002362461A1 (en) 2003-04-14

Family

ID=26929660

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002362461A Abandoned AU2002362461A1 (en) 2001-10-01 2002-10-01 Targeted therapeutic lipid constructs having cell surface targets

Country Status (2)

Country Link
AU (1) AU2002362461A1 (en)
WO (1) WO2003028643A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2410887C (en) 2000-06-02 2012-07-24 Bracco Research Usa Compounds for targeting endothelial cells, compositions containing the same and methods for their use
US8263739B2 (en) 2000-06-02 2012-09-11 Bracco Suisse Sa Compounds for targeting endothelial cells, compositions containing the same and methods for their use
AU2002245629A1 (en) * 2001-03-08 2002-09-24 Targesome, Inc. Stabilized therapeutic and imaging agents
US7794693B2 (en) 2002-03-01 2010-09-14 Bracco International B.V. Targeting vector-phospholipid conjugates
US8623822B2 (en) 2002-03-01 2014-01-07 Bracco Suisse Sa KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
US7261876B2 (en) 2002-03-01 2007-08-28 Bracco International Bv Multivalent constructs for therapeutic and diagnostic applications
EP1587944A4 (en) 2002-03-01 2007-03-21 Dyax Corp Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
PL2949658T3 (en) 2003-03-03 2018-11-30 Dyax Corp. Peptides that specifically bind HGF receptor (cMet) and uses thereof
EP1942950A2 (en) * 2005-11-01 2008-07-16 Yissum Research Development Company Of The Hebrew University Of Jerusalem Biodegradable composite for internal local radiotherapy
US20100297157A1 (en) * 2007-02-16 2010-11-25 Yasuhiro Tamaki Vaccine therapy for choroidal neovascularization
WO2010017325A2 (en) * 2008-08-05 2010-02-11 The Methodist Hospital Research Institute Thermally-activatable liposome compositions and methods for imaging, diagnosis and therapy
TW201109029A (en) 2009-06-11 2011-03-16 Oncotherapy Science Inc Vaccine therapy for choroidal neovascularization
TWI496583B (en) * 2012-02-15 2015-08-21 Univ Nat Chiao Tung Us of preparing pharmaceutical carrier and pharmaceutical composition for inhibiting angiogenesis
US10814012B2 (en) 2015-04-29 2020-10-27 University Of South Australia Compositions and methods for administering antibodies

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5512294A (en) * 1994-08-05 1996-04-30 Li; King C. Targeted polymerized liposome contrast agents
US6132764A (en) * 1994-08-05 2000-10-17 Targesome, Inc. Targeted polymerized liposome diagnostic and treatment agents
US5837283A (en) * 1997-03-12 1998-11-17 The Regents Of The University Of California Cationic lipid compositions targeting angiogenic endothelial cells

Also Published As

Publication number Publication date
WO2003028643A3 (en) 2003-10-16
WO2003028643A2 (en) 2003-04-10

Similar Documents

Publication Publication Date Title
AU2002348226A1 (en) Invasive therapeutic probe
AU2002357072A1 (en) Pseudo-antibody constructs
AU2003298738A1 (en) Liposomal formulations
WO2003018621A8 (en) Genes
AU2002953073A0 (en) Amplification of biotin-mediated targeting
AU2001263120A1 (en) Targeted elastic laminate
AU2002357860A1 (en) Enzymes
AU4735200A (en) Vitamin directed dual targeting therapy
AU2002362461A1 (en) Targeted therapeutic lipid constructs having cell surface targets
AU2003279911A1 (en) Therapeutic formulations
AU2002368044A1 (en) Co-stimulatory molecules
AU2003277910A1 (en) Ocular gene therapy
AU2001263208A1 (en) Targeting fixture
AU2003281867A1 (en) Antisense nucleic acids
AU2002347778A1 (en) Enzymes
AU2002334891A1 (en) Tumor targeted photodiagnostic-phototherapeutic agents
AU2003228648A1 (en) Securitization of sales participation certificates
AU2002332637A1 (en) Conjugates targeted to target receptors
AU2002335667A1 (en) Modified reoviral therapy
AU2001295777A1 (en) Target
AU6461400A (en) Targeted lipid particles
AU2002230890A1 (en) Targeted enzyme prodrug therapy
AU2002257273A1 (en) Enzymes
AU2001292897A1 (en) Novel therapy
AU7543200A (en) Targeted gene therapy

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase